Paper19276366
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.
Santisteban M and 12 others. Cancer Res, 2009. Cited by 327 papers, by iCite.
Cite this record
ConductScience Library. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Papers, record 19276366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19276366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mammary Neoplasms, Experimental | Major topic |
| Neoplastic Stem Cells | Major topic |
| Animals | |
| CD24 Antigen | |
| CD8-Positive T-Lymphocytes | |
| DNA Repair Enzymes | |
| Epithelial Cells | |
| Female | |
| Gene Expression | |
| Genes, erbB-2 | |
| Hyaluronan Receptors | |
| Mesoderm | |
| Mice | |
| Mice, Transgenic | |
| Mitoxantrone |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P50-CA116201 | NCI NIH HHS | United States | P50CA116201 | PubMed and NIH | NIH RePORTER |
| P50 CA116201 | NCI NIH HHS | United States | P50CA116201 | PubMed and NIH | NIH RePORTER |
| K01 CA100764 | NCI NIH HHS | United States | K01CA100764 | PubMed and NIH | NIH RePORTER |
| K01-CA100764 | NCI NIH HHS | United States | K01CA100764 | PubMed and NIH | NIH RePORTER |
| R01 CA113861 | NCI NIH HHS | United States | R01CA113861 | PubMed and NIH | NIH RePORTER |
| R01-CA113861 | NCI NIH HHS | United States | R01CA113861 | PubMed and NIH | NIH RePORTER |
| R01 CA138188 | NCI NIH HHS | United States | R01CA138188 | PubMed and NIH | NIH RePORTER |
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12427868 | EGF controls the in vivo developmental potential of a mammary epithelial cell line possessing progenitor properties. | J Cell Biol | 2002 | https://conductscience.org/library/papers/12427868 | PubMed |
| 2 | 18485877 | The epithelial-mesenchymal transition generates cells with properties of stem cells. | Cell | 2008 | https://conductscience.org/library/papers/18485877 | PubMed |
| 3 | 10086791 | A rapid single-laser flow cytometric method for discrimination of early apoptotic cells in a heterogenous cell population. | Br J Haematol | 1999 | https://conductscience.org/library/papers/10086791 | PubMed |
| 4 | 17975224 | Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. | Stem Cells | 2008 | https://conductscience.org/library/papers/17975224 | PubMed |
| 5 | 12629218 | Prospective identification of tumorigenic breast cancer cells. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12629218 | PubMed |
| 6 | 17851725 | Isolation murine mesenchymal stem cells by positive selection. | In Vitro Cell Dev Biol Anim | 2007 | https://conductscience.org/library/papers/17851725 | PubMed |
| 7 | 16360718 | Clinical management of recurrent breast cancer: development of multidrug resistance (MDR) and strategies to circumvent it. | Semin Oncol | 2005 | https://conductscience.org/library/papers/16360718 | PubMed |
| 8 | 18381452 | Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors. | Cancer Res | 2008 | https://conductscience.org/library/papers/18381452 | PubMed |
| 9 | 15989948 | Complicated tails: histone modifications and the DNA damage response. | Cell | 2005 | https://conductscience.org/library/papers/15989948 | PubMed |
| 10 | 14595126 | The profile of gene expression of human marrow mesenchymal stem cells. | Stem Cells | 2003 | https://conductscience.org/library/papers/14595126 | PubMed |
| 11 | 16428468 | Targeted modulation of MGMT: clinical implications. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16428468 | PubMed |
| 12 | 16397499 | Generation of a functional mammary gland from a single stem cell. | Nature | 2006 | https://conductscience.org/library/papers/16397499 | PubMed |
| 13 | 17229949 | The prognostic role of a gene signature from tumorigenic breast-cancer cells. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17229949 | PubMed |
| 14 | 16169465 | The transcriptional repressor Snail promotes mammary tumor recurrence. | Cancer Cell | 2005 | https://conductscience.org/library/papers/16169465 | PubMed |
| 15 | 17998939 | Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice. | Oncogene | 2008 | https://conductscience.org/library/papers/17998939 | PubMed |
| 16 | 18349857 | Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression? | Nat Clin Pract Oncol | 2008 | https://conductscience.org/library/papers/18349857 | PubMed |
| 17 | 18266270 | Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation. | Eur J Immunol | 2008 | https://conductscience.org/library/papers/18266270 | PubMed |
| 18 | 16211331 | Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals". | Breast Cancer Res Treat | 2006 | https://conductscience.org/library/papers/16211331 | PubMed |
| 19 | 17179479 | The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. | J Natl Cancer Inst | 2006 | https://conductscience.org/library/papers/17179479 | PubMed |
| 20 | 15803154 | Tumour stem cells and drug resistance. | Nat Rev Cancer | 2005 | https://conductscience.org/library/papers/15803154 | PubMed |
Cited by232
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 327 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42613325 | Role of epithelial-mesenchymal transition (EMT) in malignancies: current status and future prospects. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42613325 | PubMed |
| 41211430 | Role of EMT in drug resistance of breast cancer: molecular mechanisms and therapeutic strategies. | Front Oncol | 2025 | https://conductscience.org/library/papers/41211430 | PubMed |
| 40663561 | Masters of adaptation: How cancer and immune cell plasticity mediates tumor progression. | PLoS Biol | 2025 | https://conductscience.org/library/papers/40663561 | PubMed |
| 40003637 | Notch and Hedgehog Signaling Unveiled: Crosstalk, Roles, and Breakthroughs in Cancer Stem Cell Research. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40003637 | PubMed |
| 39635838 | Role of vascular endothelium and exosomes in cancer progression and therapy (Review). | Int J Oncol | 2025 | https://conductscience.org/library/papers/39635838 | PubMed |
| 39529126 | SpottedPy quantifies relationships between spatial transcriptomic hotspots and uncovers environmental cues of epithelial-mesenchymal plasticity in breast cancer. | Genome Biol | 2024 | https://conductscience.org/library/papers/39529126 | PubMed |
| 38692097 | Grainyhead-like-2, an epithelial master programmer, promotes interferon induction and suppresses breast cancer recurrence. | Mol Immunol | 2024 | https://conductscience.org/library/papers/38692097 | PubMed |
| 38594465 | Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase. | Cancer Gene Ther | 2024 | https://conductscience.org/library/papers/38594465 | PubMed |
| 38303523 | Effect of Pioglitazone and Cetuximab on Colon Cancer Stem-like Cell (CCSLCs) Properties. | Curr Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/38303523 | PubMed |
| 38251077 | NOP16 promotes hepatocellular carcinoma progression and triggers EMT through the Keap1-Nrf2 signaling pathway. | Technol Health Care | 2024 | https://conductscience.org/library/papers/38251077 | PubMed |
| 38244071 | The role of stromal cells in epithelial-mesenchymal plasticity and its therapeutic potential. | Discov Oncol | 2024 | https://conductscience.org/library/papers/38244071 | PubMed |
| 38243040 | Development of an invasion score based on metastasis-related pathway activity profiles for identifying invasive molecular subtypes of lung adenocarcinoma. | Sci Rep | 2024 | https://conductscience.org/library/papers/38243040 | PubMed |
| 37386520 | Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms. | Cell Biosci | 2023 | https://conductscience.org/library/papers/37386520 | PubMed |
| 36717668 | Mechanisms driving the immunoregulatory function of cancer cells. | Nat Rev Cancer | 2023 | https://conductscience.org/library/papers/36717668 | PubMed |
| 36521737 | Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics. | Semin Cancer Biol | 2023 | https://conductscience.org/library/papers/36521737 | PubMed |
| 36291900 | Resistance to Trastuzumab. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36291900 | PubMed |
| 36090045 | Machine learning-based screening of an epithelial-mesenchymal transition-related long non-coding RNA signature reveals lower-grade glioma prognosis and the tumor microenvironment and predicts antitumor therapy response. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/36090045 | PubMed |
| 35845599 | Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/35845599 | PubMed |
| 35735628 | Inflammatory Breast Cancer: The Cytokinome of Post-Mastectomy Wound Fluid Augments Proliferation, Invasion, and Stem Cell Markers. | Curr Issues Mol Biol | 2022 | https://conductscience.org/library/papers/35735628 | PubMed |
| 35392236 | Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance. | Front Oncol | 2022 | https://conductscience.org/library/papers/35392236 | PubMed |
Genes25
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19276366
GET https://conductscience.org/api/papers/v1/19276366/references?page=2